Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline
Update Informed Consent and Education Be clear if the med is FDA-approved or compounded Discuss risks and side effects Set expectations for follow-up Tell patients what to do if they have symptoms Have your consent language reviewed by a compliance expert Audit Website, Ads, and Social Check every channel (website, ads, email, SMS, booking, etc.) Delete language that misleads patients about compounded meds being FDA-approved or uses brand names wrong
Is a GLP-1 medication right for me
Free-text responses indicated providers wanted further guidance from the ASA, as current guidelines may be insufficient regarding the NPO as well as medication cessation recommendations, the article states
Genetic variants in the GLP1R gene (rs6923761) affect how densely your cells bind semaglutide, meaning that patients with certain genetic profiles may benefit from more consistent injection spacing or site rotation to maintain steady receptor saturation
